Neuropeptide Y

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 683-688

  Dumont, Yvan ^a   Quirion, Remi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958019255     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50098-2     Document Type: Chapter

References (38)

1. Baraban S.C. Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides 2004, 38:261-265.
2. Beck-Sickinger A.G. The importance of various parts of the NPY molecule for receptor recognition. Neuropeptide Y and Drug Development 1997, 107-126. Academic Press, London, UK. L. Grundemar, S.R. Bloom (Eds.).
3. Berglund M.M., Hipskind P.A., Gehlert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. (Maywood.) 2003, 228:217-244.
4. Cabrele C., Wieland H.A., Langer M., Stidsen C.E., Beck-Sickinger A.G. Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y5-receptor ligands with picomolar affinity. Peptides 2001, 22:365-378.
5. Carvajal C.C., Vercauteren F., Dumont Y., Michalkiewicz M., Quirion R. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behav. Brain Res. 2004, 153:471-480.
6. Cerda-Reverter J.M., Larhammar D. Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution. Biochem. Cell Biol. 2000, 78:371-392.
7. Chronwall B.M., Zukowska Z. Neuropeptide Y, ubiquitous and elusive. Peptides 2004, 25:359-363.
8. Dumont Y., Chabot J.G., Quirion R. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: Focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides 2004, 25:365-391.
9. Dumont Y., Jacques D., St.Pierre J.A., Tong Y., Parker R., Herzog H., Quirion R. Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains. Handbook of Chemical Neuroanatomy, Vol 16 Peptide Receptors, Part 1 Peptide Receptors, Part 1 2000, 375-475. Elsevier, London, UK. R. Quirion, A. Bjorklund, T. Hokfelt (Eds.).
10. Dumont Y., Redrobe J.P., Quirion R. Neuropeptide Y receptors. Understanding G Protein-coupled Receptors and Their Role in the CNS Molecular and Cellular Neurobiology series 2002, 372-401. Oxford University Press, Oxford, UK. M.N. Pangalos, C.H. Davies (Eds.).
11. Gehlert D.R. Introduction to the reviews on neuropeptide Y. Neuropeptides 2004, 38:135-140.
12. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
13. Hendry S.H. Organization of neuropeptide Y neurons in the mammalian central nervous system. The Biology of Neuropeptide Y and Related Peptides 1993, 65-156. Humana Press, Inc., Totawa NJ. W.F. Colmers, C. Wahlested (Eds.).
14. Kalra S.P., Kalra P.S. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 2004, 38:201-211.
15. Kalra S.P., Kalra P.S. NPY-an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction. Peptides 2004, 25:465-471.
16. Karl T., Lin S., Schwarzer C., Sainsbury A., Couzens M., Wittmann W., Boey D., von Horsten S., Herzog H. Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc. Natl. Acad. Sci. USA 2004, 101:12742-12747.
17. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., Rissanen A., Dekker J.M., Hart L.M., Valve R., Uusitupa M.I. Association of a leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 1998, 4:1434-1437.
18. Kask A., Harro J., von Horsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 2002, 26:259-283.
19. Kimmel J.R., Hayden L.J., Pollock H.G. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 1975, 250:9369-9376.
20. Lappalainen J., Kranzler H.R., Malison R., Price L.H., Van Dyck C., Rosenheck R.A., Cramer J., Southwick S., Charney D., Krystal J., Gelernter J. A functional neuropeptide YLeu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 2002, 59:825-831.
21. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 1996, 65:165-174.
22. Leibowitz S.F., Wortley K.E. Hypothalamic control of energy balance: different peptides, different functions. Peptides 2004, 25:473-504.
23. Lin S., Boey D., Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004, 38:189-200.
24. Loren I., Alumets J., Hakanson R., Sundler F. Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: preliminary immunocytochemical observations. Cell Tissue Res. 1979, 200:179-186.
25. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50:143-150.
26. Morris M.J., Tortelli G.F., Hart D.P., Delbridge L.M. Vascular and brain neuropeptide Y in banded and spontaneous hypertensive rats. Peptides 2004, 25:1313-1319.
27. Pedrazzini T. Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts. Neuropeptides 2004, 38:267-275.
28. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Characterization of neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing. J. Mol. Neurosci. 2004, 22:159-166.
29. Redrobe J.P., Dumont Y., Quirion R. Neuropeptide Y (NPY) and depression: From animal studies to the human condition. Life Sci. 2002, 71:2921-2937.
30. Redrobe J.P., Dumont Y., St.Pierre J.A., Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res. 1999, 848:153-166.
31. Sajdyk T.J., Shekhar A., Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 2004, 38:225-234.
32. Tatemoto K. neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA 1982, 79:5485-5489.
33. Thiele T.E., Naveilhan P., Ernfors P. Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides 2004, 25:975-983.
34. Thiele T.E., Sparta D.R., Hayes D.M., Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 2004, 38:235-243.
35. Thiele T.E., Stewart R.B., Badia-Elder N.E., Geary N., Massi M., Leibowitz S.F., Hoebel B.G., Egli M. Overlapping peptide control of alcohol self-administration and feeding. Alcohol Clin Exp. Res. 2004, 28:288-294.
36. Thorsell A., Rimondini R., Heilig M. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett. 2002, 332:1.
37. Vezzani A., Sperk G. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?. Neuropeptides 2004, 38:245-252.
38. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 1999, 22:25-30.